Pregabalin in the treatment of spasticity: A retrospective case series

Disability and Rehabilitation

Volumn 30, Issue 16, 2008, Pages 1230-1232

  Bradley, L J ^a   Kirker, Stephen G B ^b  

^a The Colman Clinic for Specialised Rehabilitation Services   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Gabapentin; Multiple sclerosis; Muscle relaxants; Pregabalin; Spasticity

Indexed keywords

BACLOFEN; DANTROLENE; GABAPENTIN; PREGABALIN; TIZANIDINE;

ADULT; ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MONOTHERAPY; MULTIPLE SCLEROSIS; MUSCLE SPASM; MUSCLE TONE; OUTCOMES RESEARCH; PAIN ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPASTICITY; TRAUMATIC BRAIN INJURY;

ADULT; AGED; ANTICONVULSANTS; COHORT STUDIES; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 52049109908     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.1080/09638280701602392     Document Type: Article

References (10)

1. Priebe, M. M., Sherwood, A. M., Graves, D. E., Mueller, M. and Olson, W. H. (1997) Effectiveness of gabapentin in controlling spasticity: A quantitative study. Spinal Cord, 35:3, pp. 171-175.
2. Cutter, N. C., Scott, D. D., Johnson, J. C. and Whiteneck, G. (2000) Gabapentin effect on spasticity in multiple sclerosis: A placebo-controlled, randomized trial. Arch Phys Med Rehabil, 81:2, pp. 164-169.
3. National Collaborating Centre for Chronic Conditions Multiple Sclerosis; National Clinical Guidelines for Diagnosis and Management in Primary and Secondary Care. 106. 2003, London
4. French, J. A., Kugler, A. R., Robbins, J. L., Knapp, L. E. and Garofalo, E. A. (2003) Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology, 60:10, pp. 1631-1637.
5. Rosenstock, J., Tuchman, M., LaMoreaux, L. and Sharma, U. (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain, 110:3, pp. 628-638.
6. Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S. Clusmann, H. et al. (2002) Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology, 42:2, pp. 229-236.
7. Bryans, J. S. and Wustrow, D. J. (1999) 3-substituted GABA analogs with central nervous system activity: A review. Med Res Rev, 19:2, pp. 149-177.
8. Barbara J, deLateur (2006) Evaluation of the effect of pregabalin on spasticity and function in transverse myelitis patients, 2006 Rare Neuroimmunologic Disorders Symposium
9. Mehrholz, J., Wagner, K., Meissner, D., Grundmann, K., Zange, C. Koch, R. et al. (2005) Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: A comparison study. Clin Rehabil, 19:7, pp. 751-759.
10. Haugh, A. B., Pandyan, A. D. and Johnson, G. R. (2006) A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28:15, pp. 899-907.